Document

Clinical Trial Design Considerations for Malaria Drug Development; Notice of Public Workshop; Correction

The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of Tuesday, May 10, 2016 (81 FR 28876). The document announced a public works...

The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of Tuesday, May 10, 2016 (81 FR 28876). The document announced a public workshop entitled ``Clinical Trial Design Considerations for Malaria Drug Development.'' The document was published with the incorrect title and incorrect Internet address in the Transcripts section. This document corrects those errors.

Legal Citation

Federal Register Citation

Use this for formal legal and research references to the published document.

81 FR 34348

Web Citation

Suggested Web Citation

Use this when citing the archival web version of the document.

“Clinical Trial Design Considerations for Malaria Drug Development; Notice of Public Workshop; Correction,” thefederalregister.org (May 31, 2016), https://thefederalregister.org/documents/2016-12654/clinical-trial-design-considerations-for-malaria-drug-development-notice-of-public-workshop-correction.